MYX 2.23% $4.38 mayne pharma group limited

myx a buy, page-21

  1. 6,633 Posts.
    lightbulb Created with Sketch. 615
    I have been making a lot of mistakes in my calcs lately (unfortunetly), so dont expect these to be perfect, but this is my effort to try and understand the 2H to use as a more accurate projection for 1H18 than the FY result.
    The challenge is to try and workout underlying NPAT for FY then translate that to a H2 number.
    EV/EBITDA should be more useful than PER, and it doesnt look too bad, but the H2 NPAT is bad.

    Column 1 Column 2 Column 3 Column 4 Column 5 Column 6
    1   1H17 2H17 (l.est) 2H17 (h.est) FY17 (l.est) FY17 (h.est)
    2 EBITDA (Underlying) 108.50 103.50 107.5 212.0 216.0
    3 Adjustments 20.70 (12.80) (12.80) 7.9 7.9
    4 EBITDA (Statutory) 129.20 90.70 94.7 219.9 223.9
    5 NPAT (Reported) 72.5 19.50 22.5 92 95
    6 Adjustments 15.9 -9.344 -9.344 5.767 5.767
    7 NPAT (Underlying) 56.6 28.84 31.844 86.233 89.233
    8 Shares 1532.1 1532.1 1532.1 1532.1 1532.1
    9 SP 0.765 0.765 0.765 0.765 0.765
    10 Market Cap 1172.1 1172.1 1172.1 1172.1 1172.1
    11 Net Debt 203.2 203.2 203.2 203.2 203.2
    12 EV 1375.3 1375.3 1375.3 1375.3 1375.3
    13 EV/EBITDA (underlying, annualised) 6.34 6.64 6.40 6.49 6.37
    14 EPS (underlying,annualised) 0.0739 0.0377 0.0416 0.0563 0.0582
    15 PER (underlying, annualise) 10.4 20.3 18.4 13.6 13.1
    Last edited by bug1: delete mangled rows 09/08/17
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.38
Change
-0.100(2.23%)
Mkt cap ! $372.6M
Open High Low Value Volume
$4.45 $4.53 $4.38 $514.8K 116.0K

Buyers (Bids)

No. Vol. Price($)
1 4744 $4.38
 

Sellers (Offers)

Price($) Vol. No.
$4.40 168 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.